MedPath

Asan Multivessel Registry

Recruiting
Conditions
Coronary Artery Disease
Registration Number
NCT02039752
Lead Sponsor
Seung-Jung Park
Brief Summary

The purpose of this study is to evaluate long-term prognoses of patients with multivessel coronary disease treated medically or surgically or percutaneously in real world practice.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
25000
Inclusion Criteria
  • Patients with multivessel disease from 1995 in Asan Medical Center
  • Age 19 and more
Exclusion Criteria
  • For prospective cohort, not agreeing to participate with written informed consent form

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
composite event1year

death, myocardial infarction, stroke, revascularization

Secondary Outcome Measures
NameTimeMethod
Angina symptom1year
Bleeding1year
Myocardial Infarction1year
Revascularization1year
Re-hospitalization1year
Death1year
Stroke1year
Stent thrombosis1year

by ARC(Academic Research Consortium) category

Trial Locations

Locations (1)

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Asan Medical Center
🇰🇷Seoul, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.